Ulcerative colitis High Cost Drugs pathway – under development
Crohn’s Disease High Cost Drugs pathway – under development
Ulcerative colitis High Cost Drugs pathway – under development
Crohn’s Disease High Cost Drugs pathway – under development
The documents below have been agreed by the stakeholders working in North Central London and have been approved by the NCL Joint Formulary Committee (NCL JFC). They should be used to refer appropriate patients to his/her local anticoagulation clinic for initiation of anticoagulation.
Where appropriate, local anticoagulation clinics should add their own contact details on the relevant paperwork (i.e. referral proformas, notification and transfer of care forms)
Please note that these documents may be updated intermittently. Users are also reminded that the prescribing guidance is not definitive and that other sources such as the electronic medicines compendium (SPCs) should be used for the most recent drug information. This can be found at the following link: http://www.medicines.org.uk/emc/default.aspx
Summary of Antiplatelet Options in Cardiovascular Disease
Sacubitril valsartan for heart failure position statement (NEL and NCL joint positioning)
Statin prescribing & lipid modification guideline
Stable angina prescribing guideline
Omega-3 Fatty Acids Position Statement
Guidance for the review of Omega-3 fatty acids
Guidance for the management of hypertriglyceridaemia
The following COPD guideline has been produced by the Camden, Haringey and Islington Responsible Respiratory Prescribing Group and applies to organisations that are constituent members. It has not been ratified by the NCL Joint Formulary Committee and does not apply to all organisations in NCL.
Chronic urticaria & angioedema prescribing guideline
High dose antihistamine prescribing guideline
Neuropathic pain prescribing guideline
Parkinsons disease prescribing guideline
Lidocaine 5% Patch Position Statement
Co-proxamol Tablets Position Statement
Clozapine management for patients admitted to acute hospitals guidance
Medical Cannabis Position Statement
Medical Cannabis Patient Information
Antihyperglycaemic agents for Type 2 diabetes
Insulin for Type 2 diabetes
Blood glucose and Ketone monitoring
See ‘Flash glucose monitoring‘ page
Different CCGs across London and Hertfordshire have implemented Libre differently; to identify which CCG is responsible for a given patient, enter the patient’s registered GP practice name or postcode into https://openprescribing.net/practice/
| Region | Eligibility | Blueteq form | Hospital prescribing | Libre reimbursement for Trusts | Paperwork | Manual outcome data collection |
|---|---|---|---|---|---|---|
| North Central London (Camden, Barnet, Enfield, Haringey, Islington CCGs) | LPP/LDCN criteria | Yes (initiation [inc. existing self-funders] and continuation [6m]) | New: First 6 months only Eligible self-funders: Nil | Yes | Patient-prescriber agreement | No - data collection built into NCL Blueteq form |
| North West London (Brent, Central [Westminster], Ealing, Hammersmith and Fulham, Harrow, Hillingdon, Hounslow, West [London Borough of Kensington and Chelsea and Queen’s Park and Paddington]) | LPP/LDCN criteria | Yes (initiation [inc. existing self-funders]) | First 2 months only | No | Patient-prescriber agreement Request for short term prescribing Request for long-term prescribing | Yes |
| North East London (Newham, Tower Hamlets, Waltham Forest, Barking and Dagenham, Havering, Redbridge, City and Hackney) | N,TH,WF: LPP/LDCN criteria B&D,H,R: LPP/LDCN criteria C&H: LPP/LDCN criteria | WF only: In progress Others: No | First 2 months only | No | Patient-prescriber agreement Request for short term prescribing Request for long-term prescribing | Yes |
| South East London (Bexley, Bromley, Greenwich, Lambeth, Lewisham, Southwark CCGs) | LPP/LDCN criteria | No | New: First 6 months only Eligible self-funders: Nil | Yes | Patient-prescriber agreement Request for long-term prescribing SEL APC Position Statement SEL guidance and resources | Yes |
| South West London (Croydon, Kingston, Wandsworth, Richmond, Sutton, Merton) | LPP/LDCN criteria | No | First 2 months only | No | Patient-prescriber agreement Request for short term prescribing Request for long-term prescribing | Yes |
| Hertfordshire (Herts Valleys, East & North Herts CCGs) | Herts specific criteria | Yes (initiation and every 6 months) | All | Yes | Patient-prescriber agreement (adults) Patient-prescriber agreement (paeds) | Yes |
Calcium + vitamin D (CaVitD) supplements for prevention of osteoporotic fragility fractures guideline
Vitamin D deficiency in adults with low bone mineral density guideline
Rheumatoid arthritis biologic pathway
Bisphosphonate treatment duration in women position statement
Summary of MHRA alerts for bisphosphonates and denosumab
Glucosamine & Chondroitin Supplements Position Statement
Rubefacients Position Statement